Primary Care Clinics in Marked Tree, AR Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 Kimitaka Saito, Md Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 202 Newsome Dr, Marked Tree, AR 72365 Phone: 870-358-4355 Fax: 870-358-4357 |
Riverside Clinic Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 105 Nathan St, Marked Tree, AR 72365 Phone: 870-358-2036 Fax: 870-358-4116 |
Access Medical Clinic Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 202 Newsome Dr, Marked Tree, AR 72365 Phone: 870-358-4355 Fax: 870-994-7488 |
News Archive
Lentigen receives NIH SBIR grant for program on clinical vector for TCR immunotherapy targeted to melanoma
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) Small Business Innovation Research grant (SBIR) for a program on "Clinical Vector for TCR Immunotherapy Targeted to Melanoma". In this program, Lentigen will collaborate with Dr. Michael Nishimura, Professor of Surgery, at the Medical University of South Carolina (MUSC).
Researchers at Macquarie trial new program to help improve neglected area of aged care
In a world first, researchers at the Centre for Emotional Health, Macquarie University are developing psychological treatments, which simultaneously target both anxiety and depression in older adults. Despite the fact that symptoms of anxiety and depression are typically suffered together, no program currently exists which is aimed at helping older adults tackle both disorders at once.
LFA encouraged by FDA Advisory Committee vote on BENLYSTA for autoimmune disease lupus
Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks.
Daily dose of aspirin may reduce prostate cancer risk: US Study
A US study has found that a daily dose of aspirin may reduce the risk of prostate cancer, but Cancer Research UK has noted that regular use of aspirin can cause serious side-effects and should not be undertaken unless recommended by a doctor.Several previous studies have looked at the possibility of an association between aspirin use and a reduced risk of prostate cancer.In the latest study, scientists at the Fred Hutchinson Cancer Research Centre in Seattle, led by Dr Janet Stanford, looked at data on 1,001 prostate cancer patients and a similar number of cancer-free volunteers.
Prototype ring with sensors helps to detect, prevent preterm labor
The birth of a baby is usually a joyous event, but when a child is born too early, worrisome complications can occur, including serious health problems for the baby and steep medical bills for the family. To address this, Johns Hopkins graduate students and their faculty adviser have invented a new system to pick up very early signs that a woman is going into labor too soon.
› Verified 7 days ago